This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2016-2017.
Location History:
- Menges, SI (2016)
- Menge{hacek over (s)}, SI (2017)
Company Filing History:
Years Active: 2016-2017
Title: Dominik Gaser: Innovator in Protein Expression Technologies
Introduction
Dominik Gaser is a notable inventor based in Mengeš, Slovenia. He has made significant contributions to the field of protein expression, holding 2 patents that showcase his innovative approaches. His work is primarily associated with Lek Pharmaceuticals D.d., where he continues to advance biotechnological solutions.
Latest Patents
Gaser's latest patents include a method for reducing the formation of amidated amino acids in cell lines for protein expression. This invention focuses on a method to decrease peptide amidation activity in specific cell lines, which can enhance the efficiency of protein production. Another significant patent is related to mammalian expression vectors. This invention describes new mammalian expression vectors that incorporate a novel combination of regulatory elements and selection marker genes. The vectors allow for the incorporation of multiple genes of interest, facilitating their expression and the selection of transfected cells using agents like G418 and/or MTX.
Career Highlights
Throughout his career, Dominik Gaser has demonstrated a commitment to advancing biotechnological research and applications. His work at Lek Pharmaceuticals D.d. has positioned him as a key player in the development of innovative solutions for protein expression.
Collaborations
Gaser collaborates with talented individuals such as Mihaela Skulj and Andrej Francky, contributing to a dynamic research environment that fosters innovation.
Conclusion
Dominik Gaser's contributions to the field of protein expression through his patents and work at Lek Pharmaceuticals D.d. highlight his role as an influential inventor. His innovative methods and collaborative spirit continue to drive advancements in biotechnology.